Is Peri-Operative Steroid Replacement Therapy Necessary for the Pituitary Adenomas Treated with Surgery? A Systematic Review and Meta Analysis
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with pituitary adenomas usually receive "stress dose" steroids in the peri-operative peroids. Though randomized controlled trials(RCT) have not been performed to assess the necessity of steroid coverage, there are several studies that explained the changes of adrenal function during peri-operative peroids. The aim of the present study is to investigate whether it is necessary to employ conventional peri-operative glucocorticoid replacement therapy to all the patients undergoing surgery. METHODS: We searched studies addressing peri-operative steroids coverage for pituitary adenomas in the Web of Science, Medline and the Cochrane Library. Then we extracted studies about peri-operative morning serum cortisol(MSC) levels, morbidity of early postoperative adrenal insufficiency, postoperative diabetes insipidus, relationships between MSC levels and adrenal integrity. We used RevMan Software to combine the results for meta-analysis. We used fixed-effects models for there was no significant heterogeneity existed. FINDINGS: There are 18 studies from 11 countries published between 1987 and 2013 including 1224 patients. The postoperative serum cortisol levels were significantly increased compared with the preoperative one in hypothalamic-pituitary-adrenal axis(HPAA) functions preserved patients(P<0.00001). The morbidity of early postoperative adrenal insufficiency ranged from 0.96% to 12.90%, with the overall morbidity of 5.55%(41/739). There was no significant differences of early postoperative diabetes insipidus between no supplementation patients and in supplementation patients(P=0.82). Conversely, there may be some disadvantages of high levels of cortisols such as high incidence of osteopenia and bone derangement and even the increased mortality rate. The patients with MSC levels of less than 60 nmol/l at 3 days after operation is considered as adrenal insufficient and more than 270 nmol/l as adrenal sufficient. To patients with MSC levels of 60-270 nmol/l, we need more clinical data to establish further cortisol supplementation criteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A morning cortisol measurement might be useful even after intraoperative administration of dexamethasone (237).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [237]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ciric, I., Ragin, A., Baumgartner, C., & Pierce, D. (1997) · Neurosurgery · doi:10.1097/00006123-199702000-00001 · Cited by 1,029
Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem
Salem, M., Tainsh, R. E., Bromberg, J., Loriaux, D. L., & Chernow, B. (1994) · Annals of Surgery · doi:10.1097/00000658-199404000-00013 · Cited by 357 · cited 7×
“Patients undergoing TSS usually receive “stress dose” steroids whether the hypothalamicpituitary-adrenal axis(HPAA) is deficient or preserved during TSS[2].”
BackgroundInfluentialFilipsson, H., Monson, J. P., Koltowska-Häggström, M., Mattsson, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0524 · Cited by 321 · cited 1×
“Other studies reported that high dose of cortisol replacement therapy was associated with unfavorable metabolic profile, higher intraocular pressure levels[27, 28].”
ResultValue of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency
HÄGG, E., ASPLUND, K., & LITHNER, F. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00780.x · Cited by 233 · cited 2×
“Hagg 1987[10] ITT * * * * * 200 nmol/l random 94% 86% Hagg 1987[10] ITT * * * * * 300 nmol/l random 94% 67% Auchus 1997 [6] ITT 6–30 months 60 nmol/l day3 100% 100% 270 nmol/l day3 100% 94%”
Glucocorticoid replacement therapy: are patients over treated and does it matter?
Peacey, S. R., Guo, C., Robinson, A. M., Price, A., Giles, M. A., Eastell, R., & Weetman, A. P. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.780907.x · Cited by 205 · cited 1×
“reported that high dose of cortisols were in direct proportion to high incidence of osteopenia and bone derangement[24, 25].”
BackgroundRagin, A., Baumgartner, C., Pierce, D., & Ciric, I. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70812-8 · Cited by 175
Adaptation during surgical stress. A reevaluation of the role of glucocorticoids.
Udelsman, R., Ramp, J., Gallucci, W. T., Gordon, A., Lipford, E., Norton, J. A., Loriaux, D. L., & Chrousos, G. P. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112443 · Cited by 164 · cited 1×
“concluded that there was no apparent advantage in supraphysiological glucocorticoid prophylaxis during surgical stress in primates[23].”
BackgroundInder, W. J., & Hunt, P. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8547 · Cited by 113 · cited 1×
“Though randomized controlled trials(RCT) have not been performed to assess the necessity of steroid coverage[3], there are several studies on the changes of HPAA functions associated with pituitary surgery.”
BackgroundCourtney, C. H., McAllister, A. S., McCance, D. R., Bell, P. M., Hadden, D. R., Leslie, H., Sheridan, B., & Atkinson, A. B. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01106.x · Cited by 95
AUBRY, R. H., NANKIN, H. R., MOSES, A. M., & STREETEN, D. H. P. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-11-1481 · Cited by 94
Research works printed but not linked: 1
- Page RCL, Ahlquist JAO, Adams CBT, Burke CW. Is routine steroid administration required for pituitary surgery? J Endocrinol. 1994; 140(SUPPL.): P167– ABSTRACT P167.
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
National UK guidelines for the management of paediatric craniopharyngioma
Gan, H., Morillon, P., Albanese, A., Aquilina, K., Chandler, C., Chang, Y.-C., Drimtzias, E., Farndon, S. J., Jacques, T. S., Korbonits, M., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00162-6 · Cited by 65
“64 .”
Yoon, H., Lee, H., Kim, Y. H., Lim, Y., & Park, H. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.11.085 · Cited by 50
Iatrogenic adrenal insufficiency in adults
Martin‐Grace, J., Tomkins, M., O’Reilly, M., & Sherlock, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00929-x · Cited by 40
“…and small clinical trials using this approach, it requires close monitoring of morning serum cortisol concentration in the postoperative period and, while several threshold values have been suggested to predict SAI in this context 72,78,85 , no clear consensus exists to guide this practice 74 .”
InfluentialSterl, K., Thompson, B., Goss, C. W., Dacey, R. G., Rich, K. M., Zipfel, G. J., Chicoine, M. R., Kim, A. H., & Silverstein, J. M. (2018) · Neurosurgery · doi:10.1093/neuros/nyy479 · Cited by 33
Guo, X., Zhang, D., Pang, H., Wang, Z., Gao, L., Wang, Y., Ma, W., Lian, W., Xing, B., ZS-2608 Trial Team, et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.42221 · Cited by 21
Lee, H., Yoon, H., Kim, J. H., Kim, Y. H., & Park, H. (2020) · Journal of neurosurgery · doi:10.3171/2019.11.jns192381 · Cited by 14
Jia, X., Pendharkar, A. V., Loftus, P., Dodd, R. L., Chu, O., Fraenkel, M., & Katznelson, L. (2016) · Endocrine Practice · doi:10.4158/ep161256.or · Cited by 12
Endocrinological aspects of pituitary adenoma surgery in Europe
Netuka, D., Grotenhuis, A., Foroglou, N., Zenga, F., Froehlich, S., Ringel, F. A., Samprón, N., Thomas, N., Komarc, M., Kosák, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-10300-1 · Cited by 12
Borg, H., Siesjö, P., Kahlon, B., Fjalldal, S. B., & Erfurth, E. M. (2018) · Endocrine · doi:10.1007/s12020-018-1655-8 · Cited by 12
Butenschoen, V. M., von Werder, A., Bette, S. J., Schmette, V., Schwendinger, N., Meyer, B., & Gempt, J. (2021) · Neurosurgical Review · doi:10.1007/s10143-021-01643-w · Cited by 16
Yhim, H., Oh, H.-M., Yoon, H., Kim, Y. H., & Park, H. (2019) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0000000000000638 · Cited by 10
Polovina, T. Š., Kraljević, I., Solak, M., Balaško, A., Haxhiu, A., Haxhiu, A., Dušek, T., Poljičanin, T., & Kaštelan, D. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0885-1568 · Cited by 10
National German Audit of Diagnosis, Treatment, and Teaching in Secondary Adrenal Insufficiency
Petersenn, S., Honegger, J. B., & Quinkler, M. O. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-105077 · Cited by 10
“However, most currently used perioperative replacement schemes overtreat the HPA axis and unnecessary GC administration is associated with adverse sequelae [11, 12].”
BackgroundEvaluation of different hydrocortisone treatment strategies in transsphenoidal pituitary surgery
Fridman-Bengtsson, O., Höybye, C., Porthén, L., Stjärne, P., Hulting, A., & Sunnergren, O. (2019) · Acta Neurochirurgica · doi:10.1007/s00701-019-03885-6 · Cited by 9
“The necessity of perioperative corticosteroid treatment during pituitary surgery has been debated over the years [7, 10, 15, 19, 21, 25, 26, 27].”
BackgroundJackanich, A., Tavakol, S., Strickland, B. A., Rutkowski, M. J., Kamel, D., Carmichael, J. D., Weiss, M. H., & Zada, G. (2019) · Journal of neurosurgery · doi:10.3171/2018.11.jns182521 · Cited by 8
Lower-dose perioperative steroid protocol during endoscopic endonasal pituitary adenoma resection
Pecoraro, N. C., Heiferman, D. M., Martin, B., Li, D. D., Johans, S. J., Patel, C. R., & Germanwala, A. V. (2019) · Surgical Neurology International · doi:10.25259/sni-68-2019 · Cited by 8
“[12,23] Multiple large retrospective series have noted new immediate postoperative endocrinologic dysfunction occurring in 3–14% of cases and symptomatic adrenal insufficiency occurring at a rate of about 5%.[5,14,21,23] With this, surgeons may be reluctant to withhold steroid replacement, and our survey results demon…”
BackgroundMethodResultInfluentialChacko, S. R., Abraham, A. P., Asha, H. S., Kapoor, N., Rajaratnam, S., & Chacko, A. G. (2020) · Acta Neurochirurgica · doi:10.1007/s00701-020-04530-3 · Cited by 7
Hattori, Y., Tahara, S., Aso, S., Matsui, H., Fushimi, K., Yasunaga, H., & Morita, A. (2021) · British Journal of Anaesthesia · doi:10.1016/j.bja.2021.04.006 · Cited by 7
Zou, D., Yang, Y., Gao, R., Ou, Y., Luo, J., Zhang, Z., Yang, T., & Cheng, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-03053-0 · Cited by 6
Castro, M. A., Mariño‐Sánchez, F., Fernández, A. G., Cancela, A. A., & Berrocal, V. R. (2021) · Neurocirugía · doi:10.1016/j.neucir.2021.07.004 · Cited by 6
Alexander, T. D., Collopy, S., Yu, S., Karsy, M. J., Chitguppi, C., Farrell, C. J., & Evans, J. J. (2021) · Journal of Neurological Surgery Part B Skull Base · doi:10.1055/s-0041-1735588 · Cited by 7
Barrette, L., Douglas, J. E., Chorath, K. T., Shah, M., Lu, J. S., Newman, J. G., Adappa, N. D., Kohanski, M. A., Palmer, J. N., Yoshor, D., et al. (2022) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000008893 · Cited by 4
Garg, A., Mishra, S. K., Dubey, S., Singh, V., Kuchay, M. S., & Mithal, A. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01292-8 · Cited by 4
Castro, M. A., Rodríguez‐Berrocal, V., Dios, E., Serramito-García, R., Biagetti, B., & Bernabéu, I. (2023) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2023.11.001 · Cited by 4
Venema, A. M., Kuijlen, J. M. A., van Beek, A. P., & Absalom, A. R. (2021) · British Journal of Anaesthesia · doi:10.1016/j.bja.2021.05.005 · Cited by 3
Castro, M. A., Rodríguez‐Berrocal, V., Dios, E., Serramito-García, R., Biagetti, B., & Bernabéu, I. (2023) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2023.06.004 · Cited by 5
Huisman, P. E., Siegelaar, S. E., Hoogmoed, J., Post, R., Peters, S., Gent-Houben, M. C. F., Hillebrand, J. J., Bisschop, P. H. L. T., Pereira, A. M., & Bruinstroop, E. (2024) · Pituitary · doi:10.1007/s11102-023-01374-9 · Cited by 2
“A limited number of single center studies have proposed lower cut-off values than 450 nmol/L with cortisol concentrations exceeding 350 nmol/L being already highly suggestive of normal adrenal reserve [3, 5, 6].”
BackgroundNebenniereninsuffizienz und Nebenniereninzidentalome
Pilz, S. (2017) · Wiener klinische Wochenschrift Education · doi:10.1007/s11812-016-0080-2 · Cited by 4
“verabreichtwird [13, 16, 28, 32, 33] (Anmerkung: generell sind auch bei Hypophysenoperationen Glukokokortikoide intraoperativ in der Regel nicht zwingend notwendig, obwohl dies eine weit verbreitete Praxis ist).”
BackgroundCastro, M. A., Berrocal, V. R., Dios, E., Serramito-García, R., Biagetti, B., & Bernabéu, I. (2023) · Neurocirugía (English Edition) · doi:10.1016/j.neucie.2023.07.007 · Cited by 2
Castro, M. A., Mariño‐Sánchez, F., Fernández, A. G., Cancela, A. A., & Berrocal, V. R. (2022) · Neurocirugía (English Edition) · doi:10.1016/j.neucie.2021.07.002 · Cited by 3
Batista, S., Almeida, J. A., Koester, S. W., Gasparri, L. G., Santana, L. S., Gallo, B. H. D., Palavani, L. B., Bertani, R., & Landeiro, J. A. (2023) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2023.107974 · Cited by 1
Magnaye, F. M., & Paz-Pacheco, E. T. (2025) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.040.01.06 · Cited by 1
“6 Moreover, the study of De Tomassi et al., reported that transsphenoidal surgery can be performed safely in patients with preoperative morning serum cortisol less than 9 μg/dl (250 nmol/l).”
Chinese guidelines for the diagnosis and treatment of Craniopharyngioma in children (2025)
Lin, Z., Ma, J., Mou, Y., Qi, S., Yang, X., Xu, J., Lin, Y., Liu, Y., Zhao, C., An, W., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218784 · Cited by 1
Evaluación de protocolo de manejo periquirúrgico con glucocorticoides tras cirugía hipofisaria
Echarri, A. I., García-Agulló, M. D. O., Beroiz, A. I., Mouriz, M. G., Cenoz, I. Z., Muro, S. L., de Dios, L. M., & Anda, E. (2021) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2021.06.006 · Cited by 1
Ali, A., Cai, X., Zhu, J., Geng, Y., Du, C., Feng, Y., Jin, Y., Tang, C., Cong, Z., & Ma, C. (2023) · World Neurosurgery · doi:10.1016/j.wneu.2023.08.031 · Cited by 1
Self-citationTsuang, F.-Y., Shih, S., Tseng, H., & Wang, H.-C. (2023) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2023.12.120 · Cited by 1
A Literature Review on Peri-Operative Steroid Replacement Therapy in Pituitary Adenomas Surgery
Alnahdi, H. M. (2019) · Saudi Journal of Medical and Pharmaceutical Sciences · doi:10.36348/sjmps.2019.v05i09.009
“A recent meta-analysis found that there is no difference in the incidence of postoperative AI or complications such as DI between patients receiving and those not receiving perioperative steroids [15].”
BackgroundD’Ercole, F., Gagliardi, I., Ambrosio, M. R., & Zatelli, M. C. (2022) · Springer eBooks · doi:10.1007/978-3-030-90475-3_13
Evaluation of a perioperative steroid coverage after pituitary surgery
Echarri, A. I., García-Agulló, M. D. O., Beroiz, A. I., Mouriz, M. G., Cenoz, I. Z., Muro, S. L., de Dios, L. M., & Apiñániz, E. A. (2022) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2022.04.003
39 Pituitary Adenomas Pituitary adenomas
(2021) · Thieme Medical Publishers eBooks · doi:10.1055/b-0041-180192
Manejo postoperatorio de resección de tumores cerebrales en la unidad de cuidado intensivo
Ramírez, A. F. N., Areiza, Á. D. J. M., Sánchez, B. A., Martínez, J. C. A., & Atehortúa, L. F. N. (2023) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2023.08.005 · Cited by 4
Castro, M. A., Rodríguez‐Berrocal, V., Dios, E., Serramito-García, R., Biagetti, B., & Bernabéu, I. (2023) · Neurocirugía · doi:10.1016/j.neucir.2023.07.002
周術期低用量ステロイド補充プロトコルへの変更に伴う安全性と有効性の検討
川口, 奉., 石田, 朋., & Endo, H. (2024) · Folia Endocrinologica Japonica · doi:10.1507/endocrine.100.s.hpt_12
Perioperative glucocorticoid supplementation in pituitary surgery
Castle‐Kirszbaum, M., Kam, J. K. T., Goldschlager, T., King, J. A. J., Wang, Y. Y., & Fuller, P. J. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015909
“A steroid-sparing strategy, reserving perioperative glucocorticoids for those with confirmed preoperative adrenal insufficiency and those that develop biochemical adrenal insufficiency postoperatively, is a potential alternative (Chacko 2020; Hattori 2021; Tohti 2015).”
Boya Fernández, M., & Herguedas Herguedas, L. (2018) · University of Valladolid Documentary Repository (University of Valladolid)
Role of Endocrine Testing and Preoperative Hormonal Assessment
Ghalib, L. M., Alhalalmeh, Y., & Musleh, A. (2026) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2026.09.003
Metadata
- Authors
- Tohti, M., Li, J., Zhou, Y., Hu, Y., Yu, Z., & Ma, C.
- Affiliations
- Nanjing General Hospital of Nanjing Military Command (CN)
- Corresponding author
- Ma, Chiyuan
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-16
- Volume
- 10
- Issue
- 3
- Pages
- e0119621
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4361329
- OpenAlex
- W2014179356
- Cited by
- 49
- References
- 30
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 9 · 2022: 6 · 2021: 9 · 2020: 3 · 2019: 7 · 2018: 3 · 2017: 2 · 2016: 2
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Natural Science Foundation of China (30801178)
- Nanjing University
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- pituitary adenoma, stress dose steroids, adrenal insufficiency, postoperative diabetes insipidus, hypothalamic-pituitary-adrenal axis, pituitary surgery
- MeSH terms
- Adolescent, Adrenal Insufficiency, Adult, Aged, Aged, 80 and over, Female, Glucocorticoids, Humans, Hydrocortisone, Male, Middle Aged, Pituitary Neoplasms, Hormone Replacement Therapy, Young Adult, Perioperative Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.